(Q34266228)

1 August 2017

1 reference

title

Guidelines for adults on self-medication for the treatment of acute diarrhoea (English)

1 reference

1 August 2017

0 references

Wingate D

1

1 reference

1 August 2017

Phillips SF

2

1 reference

1 August 2017

Lewis SJ

3

1 reference

1 August 2017

Malagelada JR

4

1 reference

1 August 2017

Speelman P

5

1 reference

1 August 2017

Steffen R

6

1 reference

1 August 2017

Tytgat GN

7

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

Alimentary Pharmacology & Therapeutics

1 August 2017

published in

1 reference

1 August 2017

volume

15

1 reference

1 August 2017

issue

6

1 reference

1 August 2017

page(s)

773-782

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

1 August 2017

1 reference

Review article: efficacy of infliximab in Crohn's disease--induction and maintenance of remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Adverse effect of lomotil therapy in shigellosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Bacteria and yeasts in the treatment of acute and chronic infectious diarrhea. Part I. Bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Bacteria and yeasts in the treatment of acute and chronic infectious diarrhea. Part II: Yeasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Prevention and treatment of traveler's diarrhea: a clinical pharmacological approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Apical effect of diosmectite on damage to the intestinal barrier induced by basal tumour necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

A randomized, open-label comparison of nonprescription loperamide and attapulgite in the symptomatic treatment of acute diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Loperamide. Survey of studies on mechanism of its antidiarrheal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Evaluation of gastrointestinal motility using the hydrogen breath test

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Electrochemical detector for breath hydrogen determination: measurement of small bowel transit time in normal subjects and patients with the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Loperamide abolishes exercise-induced orocecal liquid transit acceleration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Optimal dosing of trimethoprim-sulfamethoxazole when used with loperamide to treat traveler's diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Treatment of traveler's diarrhea with ciprofloxacin and loperamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Treatment of travelers' diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. A placebo-controlled, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Double blind trial of loperamide for treating acute watery diarrhoea in expatriates in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Observational Study of Travelers' Diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Ciprofloxacin and loperamide in the treatment of bacillary dysentery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

A multicenter randomized controlled trial of a liquid loperamide product versus placebo in the treatment of acute diarrhea in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Prospective, controlled, multicentre study of loperamide in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Review article: travellers' diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers' diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

Empiric antibiotic therapy for acute infective diarrhoea in the developed world

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00993.X

10.1046/J.1365-2036.2001.00993.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference